Loading…

Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis

Endometrial hyperplasia (EH) is a precursor for endometrial cancer (EC). However, biomarkers for the progression from EH to EC and standard prognostic biomarkers for EC have not been identified. In this study, we aimed to identify key genes with prognostic significance for the progression from EH to...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in genetics 2021-09, Vol.12, p.678780-678780
Main Authors: Huang, Shijin, Pang, Lihong, Wei, Changqiang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-cdc7a3c8bca8da1ada3bb6012b04b0aad96a07a8ba1c97855ba8831371fc87883
cites cdi_FETCH-LOGICAL-c442t-cdc7a3c8bca8da1ada3bb6012b04b0aad96a07a8ba1c97855ba8831371fc87883
container_end_page 678780
container_issue
container_start_page 678780
container_title Frontiers in genetics
container_volume 12
creator Huang, Shijin
Pang, Lihong
Wei, Changqiang
description Endometrial hyperplasia (EH) is a precursor for endometrial cancer (EC). However, biomarkers for the progression from EH to EC and standard prognostic biomarkers for EC have not been identified. In this study, we aimed to identify key genes with prognostic significance for the progression from EH to EC. Weighted-gene correlation network analysis (WGCNA) was used to identify hub genes utilizing microarray data (GSE106191) downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified from the Uterine Corpus Endometrial Carcinoma (UCEC) dataset of The Cancer Genome Atlas database. The Limma-Voom R package was applied to detect differentially expressed genes (DEGs; mRNAs) between cancer and normal samples. Genes with |log2 (fold change [FC])| > 1.0 and p < 0.05 were considered as DEGs. Univariate and multivariate Cox regression and survival analyses were performed to identify potential prognostic genes using hub genes overlapping in the two datasets. All analyses were conducted using R Bioconductor and related packages. Through WGCNA and overlapping genes in hub modules with DEGs in the UCEC dataset, we identified 42 hub genes. The results of the univariate and multivariate Cox regression analyses revealed that four hub genes, BUB1B , NDC80, TPX2 , and TTK , were independently associated with the prognosis of EC (Hazard ratio [95% confidence interval]: 0.591 [0.382–0.912], p = 0.017; 0.605 [0.371–0.986], p = 0.044; 1.678 [1.132–2.488], p = 0.01; 2.428 [1.372–4.29], p = 0.02, respectively). A nomogram was established with a risk score calculated using the four genes’ coefficients in the multivariate analysis, and tumor grade and stage had a favorable predictive value for the prognosis of EC. The survival analysis showed that the high-risk group had an unfavorable prognosis compared with the low-risk group ( p < 0.0001). The receiver operating characteristic curves also indicated that the risk model had a potential predictive value of prognosis with area under the curve 0.807 at 2 years, 0.783 at 3 years, and 0.786 at 5 years. We established a four-gene signature with prognostic significance in EC using WGCNA and established a nomogram to predict the prognosis of EC.
doi_str_mv 10.3389/fgene.2021.678780
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_bf4dc604d3ce4632be6de4e01b4dbb6e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_bf4dc604d3ce4632be6de4e01b4dbb6e</doaj_id><sourcerecordid>2580026464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-cdc7a3c8bca8da1ada3bb6012b04b0aad96a07a8ba1c97855ba8831371fc87883</originalsourceid><addsrcrecordid>eNpVksFu3CAQhq2qVROleYDeOPbiLRgW40ulaJWkK0VtpTbKEQ0w9pJ6IQU7VZ6hL112HVUNF9A_w_fD6K-q94yuOFfdx37AgKuGNmwlW9Uq-qo6ZVKKWhXp9X_nk-o853talug45-JtdcKFZFI0zWn1Z-swTL73FiYfA4k9AXIV51RfFzz57ocA05yQ3PlpR76lOISYJ2-PleO1YJH4QC6Di3uckoeRbA5iIrfZh4HcoR92E7oFuIkp4bh4fcHpd0w_yUWA8Sn7_K5608OY8fx5P6tury5_bD7XN1-vt5uLm9oK0Uy1dbYFbpWxoBwwcMCNkZQ1hgpDAVwngbagDDDbtWq9NqAUZ7xlvS1zUvys2i5cF-FePyS_h_SkI3h9FGIaNKTyxxG16YWzkgrHLQrJG4PSoUDKjHDFFAvr08J6mM0enS3DTDC-gL6sBL_TQ3zUSpSXrLsC-PAMSPHXjHnSe58tjiMEjHPWzVpR2kghRWllS6tNMeeE_T8bRvUhE_qYCX3IhF4ywf8CAAmt9w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580026464</pqid></control><display><type>article</type><title>Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis</title><source>PubMed Central</source><creator>Huang, Shijin ; Pang, Lihong ; Wei, Changqiang</creator><creatorcontrib>Huang, Shijin ; Pang, Lihong ; Wei, Changqiang</creatorcontrib><description>Endometrial hyperplasia (EH) is a precursor for endometrial cancer (EC). However, biomarkers for the progression from EH to EC and standard prognostic biomarkers for EC have not been identified. In this study, we aimed to identify key genes with prognostic significance for the progression from EH to EC. Weighted-gene correlation network analysis (WGCNA) was used to identify hub genes utilizing microarray data (GSE106191) downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified from the Uterine Corpus Endometrial Carcinoma (UCEC) dataset of The Cancer Genome Atlas database. The Limma-Voom R package was applied to detect differentially expressed genes (DEGs; mRNAs) between cancer and normal samples. Genes with |log2 (fold change [FC])| &gt; 1.0 and p &lt; 0.05 were considered as DEGs. Univariate and multivariate Cox regression and survival analyses were performed to identify potential prognostic genes using hub genes overlapping in the two datasets. All analyses were conducted using R Bioconductor and related packages. Through WGCNA and overlapping genes in hub modules with DEGs in the UCEC dataset, we identified 42 hub genes. The results of the univariate and multivariate Cox regression analyses revealed that four hub genes, BUB1B , NDC80, TPX2 , and TTK , were independently associated with the prognosis of EC (Hazard ratio [95% confidence interval]: 0.591 [0.382–0.912], p = 0.017; 0.605 [0.371–0.986], p = 0.044; 1.678 [1.132–2.488], p = 0.01; 2.428 [1.372–4.29], p = 0.02, respectively). A nomogram was established with a risk score calculated using the four genes’ coefficients in the multivariate analysis, and tumor grade and stage had a favorable predictive value for the prognosis of EC. The survival analysis showed that the high-risk group had an unfavorable prognosis compared with the low-risk group ( p &lt; 0.0001). The receiver operating characteristic curves also indicated that the risk model had a potential predictive value of prognosis with area under the curve 0.807 at 2 years, 0.783 at 3 years, and 0.786 at 5 years. We established a four-gene signature with prognostic significance in EC using WGCNA and established a nomogram to predict the prognosis of EC.</description><identifier>ISSN: 1664-8021</identifier><identifier>EISSN: 1664-8021</identifier><identifier>DOI: 10.3389/fgene.2021.678780</identifier><identifier>PMID: 34616422</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>co-expression analysis ; endometrial cancer ; endometrial hyperplasia ; Genetics ; nomogram ; prognostic biomarker ; survival analysis</subject><ispartof>Frontiers in genetics, 2021-09, Vol.12, p.678780-678780</ispartof><rights>Copyright © 2021 Huang, Pang and Wei. 2021 Huang, Pang and Wei</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-cdc7a3c8bca8da1ada3bb6012b04b0aad96a07a8ba1c97855ba8831371fc87883</citedby><cites>FETCH-LOGICAL-c442t-cdc7a3c8bca8da1ada3bb6012b04b0aad96a07a8ba1c97855ba8831371fc87883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488359/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488359/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Huang, Shijin</creatorcontrib><creatorcontrib>Pang, Lihong</creatorcontrib><creatorcontrib>Wei, Changqiang</creatorcontrib><title>Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis</title><title>Frontiers in genetics</title><description>Endometrial hyperplasia (EH) is a precursor for endometrial cancer (EC). However, biomarkers for the progression from EH to EC and standard prognostic biomarkers for EC have not been identified. In this study, we aimed to identify key genes with prognostic significance for the progression from EH to EC. Weighted-gene correlation network analysis (WGCNA) was used to identify hub genes utilizing microarray data (GSE106191) downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified from the Uterine Corpus Endometrial Carcinoma (UCEC) dataset of The Cancer Genome Atlas database. The Limma-Voom R package was applied to detect differentially expressed genes (DEGs; mRNAs) between cancer and normal samples. Genes with |log2 (fold change [FC])| &gt; 1.0 and p &lt; 0.05 were considered as DEGs. Univariate and multivariate Cox regression and survival analyses were performed to identify potential prognostic genes using hub genes overlapping in the two datasets. All analyses were conducted using R Bioconductor and related packages. Through WGCNA and overlapping genes in hub modules with DEGs in the UCEC dataset, we identified 42 hub genes. The results of the univariate and multivariate Cox regression analyses revealed that four hub genes, BUB1B , NDC80, TPX2 , and TTK , were independently associated with the prognosis of EC (Hazard ratio [95% confidence interval]: 0.591 [0.382–0.912], p = 0.017; 0.605 [0.371–0.986], p = 0.044; 1.678 [1.132–2.488], p = 0.01; 2.428 [1.372–4.29], p = 0.02, respectively). A nomogram was established with a risk score calculated using the four genes’ coefficients in the multivariate analysis, and tumor grade and stage had a favorable predictive value for the prognosis of EC. The survival analysis showed that the high-risk group had an unfavorable prognosis compared with the low-risk group ( p &lt; 0.0001). The receiver operating characteristic curves also indicated that the risk model had a potential predictive value of prognosis with area under the curve 0.807 at 2 years, 0.783 at 3 years, and 0.786 at 5 years. We established a four-gene signature with prognostic significance in EC using WGCNA and established a nomogram to predict the prognosis of EC.</description><subject>co-expression analysis</subject><subject>endometrial cancer</subject><subject>endometrial hyperplasia</subject><subject>Genetics</subject><subject>nomogram</subject><subject>prognostic biomarker</subject><subject>survival analysis</subject><issn>1664-8021</issn><issn>1664-8021</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVksFu3CAQhq2qVROleYDeOPbiLRgW40ulaJWkK0VtpTbKEQ0w9pJ6IQU7VZ6hL112HVUNF9A_w_fD6K-q94yuOFfdx37AgKuGNmwlW9Uq-qo6ZVKKWhXp9X_nk-o853talug45-JtdcKFZFI0zWn1Z-swTL73FiYfA4k9AXIV51RfFzz57ocA05yQ3PlpR76lOISYJ2-PleO1YJH4QC6Di3uckoeRbA5iIrfZh4HcoR92E7oFuIkp4bh4fcHpd0w_yUWA8Sn7_K5608OY8fx5P6tury5_bD7XN1-vt5uLm9oK0Uy1dbYFbpWxoBwwcMCNkZQ1hgpDAVwngbagDDDbtWq9NqAUZ7xlvS1zUvys2i5cF-FePyS_h_SkI3h9FGIaNKTyxxG16YWzkgrHLQrJG4PSoUDKjHDFFAvr08J6mM0enS3DTDC-gL6sBL_TQ3zUSpSXrLsC-PAMSPHXjHnSe58tjiMEjHPWzVpR2kghRWllS6tNMeeE_T8bRvUhE_qYCX3IhF4ywf8CAAmt9w</recordid><startdate>20210920</startdate><enddate>20210920</enddate><creator>Huang, Shijin</creator><creator>Pang, Lihong</creator><creator>Wei, Changqiang</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210920</creationdate><title>Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis</title><author>Huang, Shijin ; Pang, Lihong ; Wei, Changqiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-cdc7a3c8bca8da1ada3bb6012b04b0aad96a07a8ba1c97855ba8831371fc87883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>co-expression analysis</topic><topic>endometrial cancer</topic><topic>endometrial hyperplasia</topic><topic>Genetics</topic><topic>nomogram</topic><topic>prognostic biomarker</topic><topic>survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Shijin</creatorcontrib><creatorcontrib>Pang, Lihong</creatorcontrib><creatorcontrib>Wei, Changqiang</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Shijin</au><au>Pang, Lihong</au><au>Wei, Changqiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis</atitle><jtitle>Frontiers in genetics</jtitle><date>2021-09-20</date><risdate>2021</risdate><volume>12</volume><spage>678780</spage><epage>678780</epage><pages>678780-678780</pages><issn>1664-8021</issn><eissn>1664-8021</eissn><abstract>Endometrial hyperplasia (EH) is a precursor for endometrial cancer (EC). However, biomarkers for the progression from EH to EC and standard prognostic biomarkers for EC have not been identified. In this study, we aimed to identify key genes with prognostic significance for the progression from EH to EC. Weighted-gene correlation network analysis (WGCNA) was used to identify hub genes utilizing microarray data (GSE106191) downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified from the Uterine Corpus Endometrial Carcinoma (UCEC) dataset of The Cancer Genome Atlas database. The Limma-Voom R package was applied to detect differentially expressed genes (DEGs; mRNAs) between cancer and normal samples. Genes with |log2 (fold change [FC])| &gt; 1.0 and p &lt; 0.05 were considered as DEGs. Univariate and multivariate Cox regression and survival analyses were performed to identify potential prognostic genes using hub genes overlapping in the two datasets. All analyses were conducted using R Bioconductor and related packages. Through WGCNA and overlapping genes in hub modules with DEGs in the UCEC dataset, we identified 42 hub genes. The results of the univariate and multivariate Cox regression analyses revealed that four hub genes, BUB1B , NDC80, TPX2 , and TTK , were independently associated with the prognosis of EC (Hazard ratio [95% confidence interval]: 0.591 [0.382–0.912], p = 0.017; 0.605 [0.371–0.986], p = 0.044; 1.678 [1.132–2.488], p = 0.01; 2.428 [1.372–4.29], p = 0.02, respectively). A nomogram was established with a risk score calculated using the four genes’ coefficients in the multivariate analysis, and tumor grade and stage had a favorable predictive value for the prognosis of EC. The survival analysis showed that the high-risk group had an unfavorable prognosis compared with the low-risk group ( p &lt; 0.0001). The receiver operating characteristic curves also indicated that the risk model had a potential predictive value of prognosis with area under the curve 0.807 at 2 years, 0.783 at 3 years, and 0.786 at 5 years. We established a four-gene signature with prognostic significance in EC using WGCNA and established a nomogram to predict the prognosis of EC.</abstract><pub>Frontiers Media S.A</pub><pmid>34616422</pmid><doi>10.3389/fgene.2021.678780</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-8021
ispartof Frontiers in genetics, 2021-09, Vol.12, p.678780-678780
issn 1664-8021
1664-8021
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_bf4dc604d3ce4632be6de4e01b4dbb6e
source PubMed Central
subjects co-expression analysis
endometrial cancer
endometrial hyperplasia
Genetics
nomogram
prognostic biomarker
survival analysis
title Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A16%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20a%20Four-Gene%20Signature%20With%20Prognostic%20Significance%20in%20Endometrial%20Cancer%20Using%20Weighted-Gene%20Correlation%20Network%20Analysis&rft.jtitle=Frontiers%20in%20genetics&rft.au=Huang,%20Shijin&rft.date=2021-09-20&rft.volume=12&rft.spage=678780&rft.epage=678780&rft.pages=678780-678780&rft.issn=1664-8021&rft.eissn=1664-8021&rft_id=info:doi/10.3389/fgene.2021.678780&rft_dat=%3Cproquest_doaj_%3E2580026464%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-cdc7a3c8bca8da1ada3bb6012b04b0aad96a07a8ba1c97855ba8831371fc87883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2580026464&rft_id=info:pmid/34616422&rfr_iscdi=true